$Refractory Chronic Hand Eczema Responds to Oral Upadacitinib$

Refractory Chronic Hand Eczema Responds to Oral Upadacitinib

Saved in:

Bibliographic Details
Main Authors:	Nada Alghamdi, Abdullah AN.Aljalfan, Abdulmajeed S. Alharbi, Omar I.Alrubaish, Serene R.Almuhaidib
Format:	Article
Language:	English
Published:	Mattioli1885 2025-01-01
Series:	Dermatology Practical & Conceptual
Subjects:	Hand dermatitis, Hand Eczema, Upadacitinib, Janus kinase inhibitor.
Online Access:	https://dpcj.org/index.php/dpc/article/view/4685
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Chronic Hand Eczema (CHE): A Narrative Review
by: Gioele Ghezzi, et al.
Published: (2025-03-01)

A Practical Approach to Chronic Hand Eczema
by: Sophia A. Mense, et al.
Published: (2025-05-01)

Hand Eczema and Facial Skin Problems – Association with Occupational Exposures among Community Care Personnel in Sweden: A Cross-sectional Study
by: Thanisorn Sukakul, et al.
Published: (2025-08-01)

Chronic Hand Eczema, Real World, and Patient Centricity: A Narrative Review
by: Sonja Molin, et al.
Published: (2025-04-01)

A cross-sectional study of clinical characteristics and risk factors for hand eczema in the general Chinese population
by: Zilu Qu, et al.
Published: (2024-11-01)

Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis
by: Teppei Hagino, et al.
Published: (2024-12-01)

Hand dermatitis: a 6-year experience in a tertiary referral Brazilian hospital
by: Larissa Relva da Fonte Gonçalves Endlich, et al.
Published: (2025-08-01)

Common Contact Sensitizers among Patients with Hand Eczema: A Multicenter-Study in Nepal
by: S. Bhattarai, et al.
Published: (2016-09-01)

Common Contact Sensitizers among Patients with Hand Eczema: A Multicenter-Study in Nepal
by: S. Bhattarai, et al.
Published: (2016-09-01)

Comparison of Efficacy of Localized Narrow-Band UVB Therapy Versus Localized PUVA Therapy in Chronic Hand Eczema
by: Dhan Keshar Khadka, et al.
Published: (2023-10-01)

Comparison of Efficacy of Localized Narrow-Band UVB Therapy Versus Localized PUVA Therapy in Chronic Hand Eczema
by: Dhan Keshar Khadka, et al.
Published: (2023-10-01)

Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study
by: Stephan Weidinger, et al.
Published: (2025-03-01)

Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study
by: Teppei Hagino, et al.
Published: (2024-12-01)

Case Report: Successful management of refractory palmoplantar pustulosis with upadacitinib
by: Boyun Yang, et al.
Published: (2025-03-01)

Efficacy and Safety of Dupilumab vs Narrowband UVB for the Treatment of Chronic Hand Dermatitis: A Retrospective Study
by: Miranda K. Branyiczky, et al.
Published: (2025-05-01)

Comparative study between efficacy of topical tofacitinib 2% ointment versus topical clobetasol propionate 0.05% ointment in hand eczema at a tertiary hospital in central India [version 1; peer review: 2 approved]
by: Dr Adarshlata Singh, et al.
Published: (2024-04-01)

Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patients
by: Na Du, et al.
Published: (2024-11-01)

Health-Related Quality of Life in Chronic Hand Eczema in a Phase 2b Trial of Delgocitinib Cream
by: Timo Buhl, et al.
Published: (2025-04-01)

Upadacitinib in daily practice for refractory atopic dermatitis in adolescents: a case series of the BioDay registry
by: Florence Vroman, et al.
Published: (2025-12-01)

Upadacitinib for Treatment-Resistant Urticarial Vasculitis: A Case Study and Therapeutic Insight
by: Francesca Falcinelli, et al.
Published: (2025-04-01)

Successful Treatment of Upadacitinib in Prurigo Nodularis: A Case Report and Review of the Literature
by: Li B, et al.
Published: (2025-05-01)

Experience of using the drug upadacitinib in a child with severe atopic dermatitis
by: G. D. Alemanova, et al.
Published: (2025-06-01)

Skin diseases among adults in Tasiilaq, East Greenland
by: Morten B. Haulrig, et al.
Published: (2024-12-01)

Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry
by: Barbara Kind, et al.
Published: (2025-05-01)

A case of psoriasis and atopic dermatitis-like rash induced by interleukin-17 and interleukin-23 inhibitors successfully controlled with upadacitinib
by: Toshiki Okazaki, MD, et al.
Published: (2025-09-01)

The use of selective Janus kinase inhibitor upadacitinib in a patient with psoriatic arthritis (clinical observation)
by: Yu. A. Lushpaeva
Published: (2025-04-01)

THE ROLE OF GENETIC DETERMINANTS AND DISORDERS IN SYSTEMIC AND LOCAL IMMUNITY IN THE ETIOLOGY AND PATHOGENESIS OF HERPETIC ECZEMA (KAPOSI'S ECZEMA)
by: A. S. Stadnikova, et al.
Published: (2016-09-01)

THE CASE OF HERPETIC ECZEMA IN A CHILD WITH CONGENITAL ICHTHYOSIS AND ATOPIC DERMATITIS
by: A. S. Stadnikova, et al.
Published: (2017-03-01)

Rosacea-like eruptions associated with upadacitinib in atopic dermatitis: two case reports and management strategies
by: Claudia Paganini, et al.
Published: (2025-03-01)

A Case of Upadacitinib-Associated Ileus Secondary to Psoriasis Induced by Treatment of Atopic Dermatitis with Dupilumab
by: Liu X, et al.
Published: (2024-12-01)

Psoriasis, chronic eczema and atopic dermatitis in males: functioning of sympathoadrenal and vagoinsular systems
by: N. Yu. Reznichenko
Published: (2016-10-01)

Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?
by: Edoardo Mortato, et al.
Published: (2025-12-01)

Risk factors of eczema among pediatric groups in Qassim region, Saudi Arabia
by: Yazeed A Alghasham, et al.
Published: (2025-01-01)

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study
by: Filip Van den Bosch, et al.
Published: (2025-02-01)

When do You Suspect Immune Deficiency in a Child with Eczema?
by: Rachna S Mohite, et al.
Published: (2022-02-01)

Dupilumab Efficacy in Children with Palmoplantar Eczema
by: Nikolay N. Murashkin, et al.
Published: (2024-11-01)

Vitiligo exacerbation during upadacitinib treatment for atopic dermatitis and improvement following a switch to abrocitinib: a case report
by: Zhaoyang Wang, et al.
Published: (2025-12-01)

The management of severe eczema in pregnancy
by: E Keeling, et al.
Published: (2025-01-01)

Real-World Effectiveness and Safety of Dupilumab, Tralokinumab, and Upadacitinib in Patients with Atopic Dermatitis: A 52-Week International, Multicenter Retrospective Cohort Study
by: Tiago Torres, et al.
Published: (2025-06-01)

Case Report: Upadacitinib in the management of refractory urticarial vasculitis
by: Maan M. Almaghrabi, et al.
Published: (2025-08-01)